Skip to content

Nina Abukahok

3 papers in the library · 7 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental and Clinical Pharmacology July 1, 2026 Nina Abukahok, Steven Lawrence, Samrachana Adhikari et al.

Ketamine is increasingly prescribed in an off-label manner to treat psychiatric disorders, raising concerns about direct-to-consumer advertising and the proliferation of clinics offering ketamine for at-home use without direct medical supervision. We aimed to identify and characterize clinics advertising ketamine for psychiatric conditions online in the New York metropolitan area (New York, New...

DOI: 10.1111/fcp.70095 (opens in new tab) Full text (opens in new tab) Ketamine Direct‐to‐consumer advertising Off‐label prescribing Telehealth

Tusi use among the New York City nightclub-attending population.

Addiction April 20, 2025 Joseph J Palamar, Nina Abukahok, Patricia Acosta et al. 7 citations

'Tusi', also known as 'tusibí' or 'pink cocaine', is a drug concoction which previously emerged in Latin America and Europe and has recently acquired popularity in the United States (US). Consumers are often unaware that Tusi contains a mixture of ketamine and other drugs, and the concoction can be confused with 2C/2C-B (ring-substituted phenethylamines/4-bromo-2,5-dimethoxyphenethylamine) or...

An Update on the Epidemiology of Tusi ("Pink Cocaine").

Current Addiction Reports 2025 Nina Abukahok, Nicole D. Fitzgerald, Joseph J Palamar

Tusi, also known as "pink cocaine," has emerged across nightlife scenes in Latin America, Europe, Australia, and the United States (US). Tusi is typically a drug mixture containing ketamine and 3,4-methylenedioxymethamphetamine (MDMA). Due to tusi's inconsistent chemical makeup, surveillance and harm reduction efforts have proven difficult for researchers and consumers alike. This review...